These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia. Saklamaz A, Comlekci A, Temiz A, Caliskan S, Ceylan C, Alacacioglu A, Yesil S. Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299 [Abstract] [Full Text] [Related]
23. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency. Elgzyri T, Castenfors J, Hägg E, Backman C, Thorén M, Bramnert M. Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653 [Abstract] [Full Text] [Related]
25. [Familial hypercholesterolemia--intensive diet therapy combined with drug therapy]. Stugaard M, Wiig I, Lund H, Ose L, Norseth J. Tidsskr Nor Laegeforen; 1992 Aug 30; 112(20):2642-6. PubMed ID: 1412289 [Abstract] [Full Text] [Related]
26. [Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. II. Results of the treatment in relation to the type of hyperlipoproteinemia]. Sznajd J, Idzior-Waluś B, Korzus G, Zabiński J, Hebda A, Markiewicz M. Przegl Lek; 1990 Aug 30; 47(10):711-4. PubMed ID: 2089450 [Abstract] [Full Text] [Related]
27. Plafibride treatment and serum lipids in hyperlipoproteinemias. Rodriguez F, López IM, Jover E. J Med; 1987 Aug 30; 18(3-4):153-63. PubMed ID: 3323393 [Abstract] [Full Text] [Related]
30. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits. Mendoza S, Gamez R, Mas R, Goicochea E. Int J Tissue React; 2003 Aug 30; 25(3):81-9. PubMed ID: 14756189 [Abstract] [Full Text] [Related]
35. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW. Chin Med J (Engl); 2004 Feb 30; 117(2):163-7. PubMed ID: 14975195 [Abstract] [Full Text] [Related]
36. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs. Wechsler JG, Hutt V, Klör HU, Ditschuneit H. Artery; 1980 Feb 30; 8(6):519-29. PubMed ID: 7259531 [Abstract] [Full Text] [Related]
37. [Pleiotropic effects of micronized fenofibrate in patients with combined hyperlipidemia]. Okopień B, Cwalina Ł, Haberka M, Kowalski J, Zieliński M, Szwed Z, Kalina Z, Herman ZS. Pol Merkur Lekarski; 2002 Dec 30; 13(78):465-9. PubMed ID: 12666442 [Abstract] [Full Text] [Related]
39. [Clinical effectiveness of acipimox and fenofibrate in patients with hyperlipoproteinemia type II]. Chojnowska-Jezierska J, Jabłoński S, Tkaczewski W. Wiad Lek; 1993 May 30; 46(9-10):332-6. PubMed ID: 8236987 [Abstract] [Full Text] [Related]
40. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia. Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I. Kardiol Pol; 2004 Jun 30; 60(6):567-77. PubMed ID: 15334157 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]